These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8717309)

  • 41. The influence of steroid therapy in patients with IgA nephropathy.
    Masaki T; Yorioka N; Yamakido M
    Nephron; 2000 Oct; 86(2):197-8. PubMed ID: 11014996
    [No Abstract]   [Full Text] [Related]  

  • 42. Early steroid therapy in IgA nephropathy: still an open question.
    Piccoli A; Borsatti A
    Nephron; 1989; 51(2):289-91. PubMed ID: 2915774
    [No Abstract]   [Full Text] [Related]  

  • 43. A case of sarcoidosis in a patient with IgA nephropathy.
    Kahn A; Hodges N; Lord M
    MedGenMed; 2005 Mar; 7(1):7. PubMed ID: 16369312
    [No Abstract]   [Full Text] [Related]  

  • 44. [IgA nephropathy in a patient with ulcerative colitis].
    Soejima A; Nakabayasi K; Kitamoto K; Nagasawa T; Matsumoto K; Kozaki M
    Nihon Naika Gakkai Zasshi; 1988 May; 77(5):685-9. PubMed ID: 3216139
    [No Abstract]   [Full Text] [Related]  

  • 45. [Concomitant therapy with prednisolone and cyclophosphamide in 18 cases of IgA nephropathy].
    Kawaguchi S; Matsuzaki T; Sato R; Katsumata Y
    Nihon Naika Gakkai Zasshi; 1986 May; 75(5):611-7. PubMed ID: 3746074
    [No Abstract]   [Full Text] [Related]  

  • 46. Patients with IgA nephropathy have altered levels of immunomodulatory C19 steroids. Glucocorticoid therapy with addition of adrenal androgens may be the choice.
    Šterzl I; Hill M; Stárka L; Velíková M; Kančeva R; Jemelková J; Czerneková L; Kosztyu P; ZadraŽil J; Matoušovic K; Vondrák K; Raška M
    Physiol Res; 2017 Sep; 66(Suppl 3):S433-S442. PubMed ID: 28948828
    [TBL] [Abstract][Full Text] [Related]  

  • 47. National survey on status of steroid therapy for cardiac sarcoidosis in Japan.
    Hiramitsu S; Morimoto S; Uemura A; Kato Y; Kimura K; Ohtsuki M; Kato S; Sugiura A; Miyagishima K; Hishida H; Sugisaki K; Tsuda T
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):210-3. PubMed ID: 16315784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Steroid therapy is effective for IgA nephropathy after liver transplantation in a pediatric patient.
    Tamura H; Kuraoka S; Nakazato H
    Clin Case Rep; 2021 May; 9(5):e04237. PubMed ID: 34026195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW; Fluck RJ; Lambie SH
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effects of methylprednisolone pulse therapy on progressive IgA nephropathy].
    Yoshimura M; Kida H; Saito Y; Takaeda M; Sugioka G
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):761-8. PubMed ID: 1770636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of steroid therapy in IgA nephropathy].
    Ohashi T; Shimokawahara H; Fukumoto M; Azuma K; Uchida Y; Tokuda Y; Ito H; Yasumoto Y; Yamashita W; Harada R
    Fukuoka Igaku Zasshi; 1992 May; 83(5):209-15. PubMed ID: 1612550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Study on a predictive marker for evaluating the effectiveness of steroid therapy in IgA nephropathy-significance of extracapillary changes].
    Yamamoto S; Iesato K; Yoshida H; Hori J; Hasegawa R; Ohta Y; Akikusa B; Kondo Y
    Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):74-83. PubMed ID: 8717309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IgA nephropathy (IgAN) presenting with the nephrotic syndrome.
    Oviasu E
    Trop Geogr Med; 1992 Oct; 44(4):365-8. PubMed ID: 1295149
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.